After oral administration the fraction of drug reaching the systemic circulation in unchanged form is:
So the term I'm thinking of here is bioavailability. Bioavailability is the fraction of the administered dose that reaches the systemic circulation in an active form. For oral drugs, if they undergo significant first-pass metabolism, their bioavailability would be lower. For example, drugs like propranolol have low bioavailability because they're heavily metabolized by the liver.
The options aren't listed, but the correct answer is probably "Bioavailability." Let me check the options again. The question is asking for the term that describes the unchanged drug reaching systemic circulation. So the answer should be bioavailability.
Wait, other terms might be involved. Is it hepatic extraction ratio? No, that's how much the liver removes the drug. First-pass effect is the phenomenon, but the question is about the fraction itself. So bioavailability is the correct term here. The other options might be things like absorption rate, half-life, or something else. But since the question is specifically about the fraction reaching systemic circulation, bioavailability is the key concept here.
**Core Concept**
This question tests understanding of **bioavailability**, a pharmacokinetic parameter defined as the **fraction of an administered drug dose that reaches systemic circulation unchanged**. It accounts for absorption efficiency and first-pass metabolism in the liver and gut.
**Why the Correct Answer is Right**
Oral drugs must pass through the gastrointestinal tract and liver before entering systemic circulation. **Bioavailability** quantifies the proportion of the drug that survives these processes. For example, a drug with 50% bioavailability means only half the ingested dose reaches systemic circulation in active form. This metric is critical for determining dosing regimens and comparing drug formulations.
**Why Each Wrong Option is Incorrect**
**Option A:** *First-pass metabolism* refers to the metabolic process itself, not the resulting fraction.
**Option B:** *Hepatic extraction ratio* measures how much the liver removes the drug, not the systemic fraction.
**Option C:** *Absorption rate* describes how quickly the drug enters circulation, not the total amount.
**Clinical Pearl / High-Yield Fact**
Drugs with high first-pass metabolism (e.g., **propranolol**, **lidocaine**) have low bioavailability and are often administered intravenously to bypass hepatic metabolism. Always consider bioavailability when comparing oral vs. IV dosing.
**Correct Answer: D. Bioavailability**